Abstract:Epidemiological studies suggest that increased intake of fruits and vegetables may be associated with a reduced risk of prostate cancer. Apigenin (4', 5, 7,-trihydroxyflavone), a common dietary flavonoid abundantly present in fruits and vegetables, has shown remarkable anti-proliferative effects against various malignant cell lines. However, the mechanisms underlying these effects remain to be elucidated. We investigated the in vivo growth inhibitory effects of apigenin on androgen-sensitive human prostate carcinoma 22Rv1 tumor xenograft subcutaneously implanted in athymic male nude mice. Apigenin was administered to mice by gavage at doses of 20 and 50 mug/mouse/day in 0.2 ml of a vehicle containing 0.5% methyl cellulose and 0.025% Tween 20 in two different protocols. In the first protocol, apigenin was administered for 2 wk before inoculation of tumor and was continued for 8 wk, resulting in significant inhibition of tumor volume by 44 and 59% (P<0.002 and 0.0001), and wet weight of tumor by 41 and 53% (P<0.05), respectively. In the second protocol, administration of apigenin began 2 wk after tumor inoculation and continued for 8 wk; tumor volume and wet weights of tumor were reduced by 39 and 53% (P<0.01 and 0.002) and 31 and 42% (P<0.05), respectively. The tumor inhibitory effect of apigenin was more pronounced in the first protocol of extended treatment, which was associated with increased accumulation of human IGFBP-3 in mouse serum along with significant increase in IGFBP-3 mRNA and protein expression in tumor xenograft. Apigenin intake by these mice also resulted in simultaneous decrease in serum IGF-I levels and induction of apoptosis in tumor xenograft. Importantly, tumor growth inhibition, induction of apoptosis, and accumulation of IGFBP-3 correlated with increasing serum and tumor apigenin levels. In both studies, animals did not exhibit any signs of toxicity or reduced food consumption. In cell culture studies, apigenin treatment resulted in cell growth inhibition and induction of apoptosis, which correlated with increased accumulation of IGFBP-3 in culture medium and cell lysate. These effects were associated with significant reduction in IGF-I secretion; inhibition of IGF-I-induced cell cycle progression and insulin receptor substrate-1 (IRS-1) tyrosine phosphorylation, along with an increase in sub-G1 peak by apigenin. Further, treatment of cells with IGFBP-3 antisense oligonucleotide reversed these effects and attenuated apigenin-mediated inhibition of IRS-1 phosphorylation conferring inhibitory effects of apigenin on IGF-signaling. This study presents the first evidence that the in vitro and in vivo growth inhibitory effects of apigenin involve modulation of IGF-axis signaling in prostate cancer.

Abstract 3290: Modulation of AKT, ERK and Mcl-1 by Apigenin Sensitizes Colon Cancer Cells to Anti-Tumor Activities of ABT263.

Apigenin Sensitizes Colon Cancer Cells to Antitumor Activity of Abt-263

Apigenin Suppresses Glut-1 And P-Akt Expression To Enhance The Chemosensitivity To Cisplatin Of Laryngeal Carcinoma Hep-2 Cells: An In Vitro Study

Supplementary Figure 6 from Apigenin Sensitizes Colon Cancer Cells to Antitumor Activity of ABT-263

Anti-proliferation and Chemo-Sensitization Effects of Apigenin on Human Lung Cancer Cells

Supplementary Figure 3 from Apigenin Sensitizes Colon Cancer Cells to Antitumor Activity of ABT-263

Supplementary Figure 2 from Apigenin Sensitizes Colon Cancer Cells to Antitumor Activity of ABT-263

BH3 Mimetic ABT-263 Enhances the Anticancer Effects of Apigenin in Tumor Cells with Activating EGFR Mutation

Supplementary Figure 7 from Apigenin Sensitizes Colon Cancer Cells to Antitumor Activity of ABT-263

Autophagy Inhibition Enhances Apigenin-Induced Apoptosis in Human Breast Cancer Cells.

Apigenin Up-Regulates Transgelin and Inhibits Invasion and Migration of Colorectal Cancer Through Decreased Phosphorylation of AKT

Apigenin Potentiates TRAIL Therapy of Non-Small Cell Lung Cancer Via Upregulating DR4/DR5 Expression in a P53-Dependent Manner

Up‐regulation of insulin‐like growth factor binding protein‐3 by apigenin leads to growth inhibition and apoptosis of 22Rv1 xenograft in athymic nude mice

Apigenin Restrains Colon Cancer Cell Proliferation Via Targeted Blocking of Pyruvate Kinase M2-Dependent Glycolysis

Abstract 2260: Novel Molecular Therapy Targeting Mcl-1 and Modulating Autophagy in Castration-Resistant Prostate Cancer

Apigenin Suppresses PD-L1 Expression in Melanoma and Host Dendritic Cells to Elicit Synergistic Therapeutic Effects

Apigenin Combined With Gefitinib Blocks Autophagy Flux and Induces Apoptotic Cell Death Through Inhibition of HIF-1α, c-Myc, p-EGFR, and Glucose Metabolism in EGFR L858R+T790M-Mutated H1975 Cells

Abstract 523: Aronia berry and oligomeric proanthocyanidins synergistically exhibit anticancer effects in colorectal cancer by inhibiting LMNB1

Therapeutic Potential of Apigenin, a Plant Flavonoid, for Imatinib-Sensitive and Resistant Chronic Myeloid Leukemia Cells

Preclinical Development Synergistic Antitumor Activity of Gemcitabine and ABT-737 In Vitro and In Vivo through Disrupting the Interaction of USP 9 X and Mcl-1

Effect of apigenin on the multidrug resistant breast cancer cell line MCF-7/ADR